Ticker
RIGLCompany Name
RIGEL PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Goodwill and Intangibles | Tangible Assets |
---|---|---|---|
6/30/2025 | $ 206.74M | $ 25.92M | $ 180.81M |
3/31/2025 | $ 175.97M | $ 26.51M | $ 149.46M |
12/31/2024 | $ 163.98M | $ 27.1M | $ 136.88M |
9/30/2024 | $ 139.42M | $ 27.69M | $ 111.73M |
6/30/2024 | $ 128.41M | $ 28.27M | $ 100.13M |
3/31/2024 | $ 126.52M | $ 28.86M | $ 97.66M |
12/31/2023 | $ 117.22M | $ 13.88M | $ 103.35M |
9/30/2023 | $ 115.32M | $ 14.15M | $ 101.18M |
6/30/2023 | $ 117.09M | $ 14.41M | $ 102.68M |
3/31/2023 | $ 123.61M | $ 14.68M | $ 108.93M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Assets - Intangibles
(=) Tangible Assets
Tangible Assets for RIGEL PHARMACEUTICALS INC is calculated as follows: Assets [ $ 123.06M ] - Intangibles [ $ 0 ]
(=) Tangible Assets [ $ 123.06M ]
Minimum
Mar 31, 2024
Maximum
Mar 31, 2021
Average
Median
filtered constituents | 3.47K |
---|---|
min | $ 0 |
max | $ 5.31B |
average | $ 996.21M |
median | $ 389.26M |
std | $ 1.28B |